CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Conversion Chief Executive Officer acquired 5,953 shares (conversion)
- 4 Conversion Director acquired 59,524 shares (conversion)
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 4 Open-market sale 10% owner sold 130,200 shares at an average $4.19 ($545,246)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
Page 22 of 28 · 547 filings